1672-88-4O=C1CN(/N=C/C=C/c2ccc([N+](=O)[O-])o2)C(=O)N1DECBQELQORZLLP-UAIOPKHMSA-NNitrofuran derivative anti-infective agent used for urinary tract infections.
1672-88-4DTXSID101030908CHEMBL3707254Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
UsesFuragin (a nitrofurantoin analog) has the same efficacy in treating acute cystitis as Ciprofloxacin, however the duration of therapy is longer. Antibacterial.
DefinitionChEBI: An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [3-(5-nitro-2-furyl)prop-2-en-1-ylidene]amino group (the configuration of the C2C and C2 bonds in the grouping that links the two heterocycles is not specified). A nitrofuran antibiotic with properties similar to nitrofurantoin, furagin is used in the treatment of urinary tract infections.
No reaction records under the current filter.
Loading…